TVA Medical, Inc. is a medical device company based in Austin, Texas, that specializes in the development and manufacture of catheter-based equipment and solutions aimed at treating end-stage renal disease (ESRD) and peripheral vascular diseases. Founded in 2009, TVA Medical focuses on creating innovative and minimally invasive therapies to improve patient outcomes. The company has garnered funding from Santé Ventures and operates as a subsidiary of Becton, Dickinson and Company since July 2018.
MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.
NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, established in 2007. It focuses on developing innovative products for the prevention and treatment of metabolic diseases related to over-nutrition, such as obesity and type 2 diabetes. The company's technology platform combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to reduce the dosage of metformin, a standard treatment for early-stage type 2 diabetes, which some patients find difficult to tolerate due to side effects. NuSirt's lead product, NS-0100, combines leucine with a low dose of metformin and is currently undergoing Phase 2 clinical trials to determine its efficacy. The company has filed eleven patent applications, with two patents issued, and has conducted multiple pre-clinical and clinical studies to support its patented technologies. NuSirt has also formed strategic partnerships to enhance its research and development efforts in the field.
Evermind, Inc. is a Nashville-based company that offers innovative solutions for monitoring home appliances, primarily aimed at providing peace of mind for individuals living alone and their caregivers. Founded in 2012, Evermind's technology sends notifications via text messages or emails when appliances are used or not used within specified timeframes. This includes common devices such as microwave ovens, coffee makers, TVs, lamps, and medical equipment. By tracking these everyday activities, Evermind allows family members and friends to receive subtle signals about their loved ones' well-being, akin to traditional community observations, without intruding on their privacy or altering their routines.
Advanced Catheter Therapies, Inc. is an early-stage medical device company focused on the research and development of catheter technologies designed to address various vascular diseases, such as thrombosis, inflammation, occlusions, and restenosis. The company's key product, the Occlusion Perfusion Catheter, is a multi-lumen balloon catheter that temporarily restricts blood flow to enable localized delivery of therapeutic agents within the peripheral and coronary vasculature. Additionally, Advanced Catheter Therapies is developing devices specifically aimed at preventing restenosis, or the re-blockage of blood vessels, as well as catheters for endovascular debulking, which involves clearing blocked blood vessels. Founded in 2008 and based in Chattanooga, Tennessee, the company was previously known as Atlanta Catheter Therapies, Inc. before rebranding in October 2011.
MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.
Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.
Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.
Preferral is a referral management system that enhances the efficiency of patient referrals between primary care practices and specialists. Founded in 2013 and headquartered in Nashville, Tennessee, Preferral offers an online platform that allows practices to easily incorporate referral forms on their websites. This enables patients to schedule appointments at their convenience, leading to instant referral bookings. The system streamlines communication and reduces administrative costs for healthcare providers without the need for complex electronic health record integrations. Additionally, Preferral provides valuable insights into referral relationships, helping practices improve their marketing efforts and optimize patient care.
InvisionHeart draws on the strengths of experienced leadership, robust software and hardware developers and a strong clinical advisory team. The technology was originally developed by a team of physicians and engineers at Vanderbilt University in response to real-world clinical problems. Along with their team of investors, they share a vision for the improved care of heart patients wherever they live and work.
Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet that live streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible.
Bjond Inc., founded in 2012 and based in Columbus, Ohio, operates in the technology sector with a focus on healthcare software. The company specializes in automated workflow and real-time decision support tools designed to assist patients in making informed choices and facilitating behavior change. Its software provides a dynamic and engaging platform for users, allowing individuals and businesses to create interactive content and expert workflows with minimal technical expertise. By leveraging a continuous cycle of data-driven care, Bjond aims to enhance patient outcomes and improve overall quality of life across various industries and situations.
GenomOncology, LLC is a Cleveland-based genomics technology and services company dedicated to enhancing precision medicine by converting next-generation sequencing (NGS) data into actionable insights for clinicians and researchers. The company offers the GO Clinical Workbench, a decision support tool that translates raw sequencing data into detailed clinical reports based on the molecular profile of each patient's tumor genome. Additionally, GenomOncology provides GenomAnalytics, a research platform facilitating rapid, near real-time genome analysis and exploration for new discoveries. IgniteIQ is another solution offered, which extracts clinically relevant data from various reports and converts it into discrete data elements. The company also supports assay validation, integration with laboratory information systems, and custom feature development. Established in 2012, GenomOncology aims to improve patient outcomes through advanced data interpretation in oncology.
Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.
Quire, LLC specializes in transforming unstructured clinical notes and electronic medical record (EMR) text into accessible, actionable data for population health management. The company’s platform allows healthcare organizations to categorize, organize, and visualize patient information, enabling the identification and treatment of high-risk patients and the targeting of healthcare spending demographics. By integrating social and environmental factors into its analysis, Quire provides insights that help practices understand patient risk across their populations. The system supports predictive modeling, provider evaluation, and resource allocation, facilitating effective interventions and cost reduction. Founded in 2003 and based in Memphis, Tennessee, Quire was previously known as Computable Genomix, LLC.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.
Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.
VenX Medical LLC is a medical device company based in Nashville, Tennessee, specializing in the treatment of varicose veins associated with venous insufficiency. Founded in 2009, the company has developed innovative devices, including VenX Reach, a disposable device designed for the treatment of small and medium-sized lower limb veins, such as reticular and spider veins. This device can be used as a standalone treatment or in conjunction with other vein therapies, including endovenous ablation and sclerotherapy. Additionally, VenX Medical offers Nanophlebectomy, a handheld device that targets spider and reticular veins by disrupting the vein layers to induce coagulation. These technologies aim to provide effective and minimally invasive options for patients suffering from various venous conditions.
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.
Preferral is a referral management system that enhances the efficiency of patient referrals between primary care practices and specialists. Founded in 2013 and headquartered in Nashville, Tennessee, Preferral offers an online platform that allows practices to easily incorporate referral forms on their websites. This enables patients to schedule appointments at their convenience, leading to instant referral bookings. The system streamlines communication and reduces administrative costs for healthcare providers without the need for complex electronic health record integrations. Additionally, Preferral provides valuable insights into referral relationships, helping practices improve their marketing efforts and optimize patient care.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
TVA Medical, Inc. is a medical device company based in Austin, Texas, that specializes in the development and manufacture of catheter-based equipment and solutions aimed at treating end-stage renal disease (ESRD) and peripheral vascular diseases. Founded in 2009, TVA Medical focuses on creating innovative and minimally invasive therapies to improve patient outcomes. The company has garnered funding from Santé Ventures and operates as a subsidiary of Becton, Dickinson and Company since July 2018.
Evermind, Inc. is a Nashville-based company that offers innovative solutions for monitoring home appliances, primarily aimed at providing peace of mind for individuals living alone and their caregivers. Founded in 2012, Evermind's technology sends notifications via text messages or emails when appliances are used or not used within specified timeframes. This includes common devices such as microwave ovens, coffee makers, TVs, lamps, and medical equipment. By tracking these everyday activities, Evermind allows family members and friends to receive subtle signals about their loved ones' well-being, akin to traditional community observations, without intruding on their privacy or altering their routines.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.
Quire, LLC specializes in transforming unstructured clinical notes and electronic medical record (EMR) text into accessible, actionable data for population health management. The company’s platform allows healthcare organizations to categorize, organize, and visualize patient information, enabling the identification and treatment of high-risk patients and the targeting of healthcare spending demographics. By integrating social and environmental factors into its analysis, Quire provides insights that help practices understand patient risk across their populations. The system supports predictive modeling, provider evaluation, and resource allocation, facilitating effective interventions and cost reduction. Founded in 2003 and based in Memphis, Tennessee, Quire was previously known as Computable Genomix, LLC.
Cerebrotech Medical Systems, Inc. is focused on developing non-invasive monitoring technology for patients recovering from stroke or traumatic brain injury. The company's primary product, the Cerebrotech monitor, is designed to detect early signs of cerebral fluid accumulation, such as edema or bleeding, which can arise from various neurological conditions. By providing continuous monitoring, the device alerts healthcare providers to increases in brain fluids before intracranial pressure spikes, thus enabling timely interventions to prevent potential brain damage. Founded in 2010 and based in Pleasanton, California, Cerebrotech aims to enhance patient outcomes by reducing treatment delays during neurological assessments.
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.
MedCenterDisplay, LLC specializes in digital patient satisfaction and engagement solutions for hospitals and clinics across the United States. Founded in 2007 and based in Brentwood, Tennessee, the company offers a comprehensive range of services, including digital signage, online marketing, and application development, aimed at enhancing patient engagement and satisfaction. Their innovative digital signage systems are designed to effectively communicate with patients and their families while they wait for medical services. Additionally, MedCenterDisplay provides online marketing solutions such as search engine optimization, reputation management, social media support, and website development. The company's services are tailored to improve healthcare outcomes, reduce avoidable readmissions, and enhance patient experience metrics like HCAHPS. MedCenterDisplay operates as a subsidiary of PatientPoint, LLC, further solidifying its role in the healthcare marketing landscape.
Diabetes Care Group, Inc. provides diabetes clinical care services for individuals with diabetes. It offers medical management, patient education and personalized counseling, behavioral modification, diet and nutrition, specialized medical treatment, blood glucose monitoring, point-of-care laboratory, and data management services to improve patient self-management and clinical outcomes. Diabetes Care Group, Inc. was formerly known as Diabetes Care Associates, Inc. The company was founded in 1986 and is based in Jackson, Mississippi. Diabetes Care Group, Inc. operates as a subsidiary of Renal Care Group, Inc.
Cerebrotech Medical Systems, Inc. is focused on developing non-invasive monitoring technology for patients recovering from stroke or traumatic brain injury. The company's primary product, the Cerebrotech monitor, is designed to detect early signs of cerebral fluid accumulation, such as edema or bleeding, which can arise from various neurological conditions. By providing continuous monitoring, the device alerts healthcare providers to increases in brain fluids before intracranial pressure spikes, thus enabling timely interventions to prevent potential brain damage. Founded in 2010 and based in Pleasanton, California, Cerebrotech aims to enhance patient outcomes by reducing treatment delays during neurological assessments.
Diabetes Care Group, Inc. provides diabetes clinical care services for individuals with diabetes. It offers medical management, patient education and personalized counseling, behavioral modification, diet and nutrition, specialized medical treatment, blood glucose monitoring, point-of-care laboratory, and data management services to improve patient self-management and clinical outcomes. Diabetes Care Group, Inc. was formerly known as Diabetes Care Associates, Inc. The company was founded in 1986 and is based in Jackson, Mississippi. Diabetes Care Group, Inc. operates as a subsidiary of Renal Care Group, Inc.
Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.
OnFocus Healthcare, originally established in 1985 as a healthcare strategic planning consulting firm, transitioned in 2008 to focus on business execution software solutions. It specializes in providing enterprise performance management (EPM) software and support services tailored for the healthcare sector. Its flagship product, onFocus epm™, is designed to enhance patient care by enabling hospitals to improve their operational performance and execution capabilities. The software facilitates effective communication, management, and tracking of plans, metrics, and resources, promoting accountability within healthcare organizations. OnFocus Healthcare aims to boost the performance of its clients by at least 20%, supporting executives, managers, and employees in their efforts to deliver better, faster, and more cost-effective care.
Molecular Sensing, Inc. is a drug discovery and life sciences research instrumentation company that specializes in biophysical characterization of small molecule interactions with complex drug targets. Founded in 2011 and based in Nashville, Tennessee, the company commercializes a unique assay technology known as Back-Scattering Interferometry (BSI), which allows for label-free and conformation-sensitive detection of biomolecular interactions in free-solution environments. This technology supports a range of applications, including assay development, secondary screening, and mechanism-of-action studies, particularly for allosteric and complex targets. By enabling the measurement of unlabeled binding affinities and target engagement verification, Molecular Sensing provides pharmaceutical companies with advanced tools to enhance drug discovery processes.
Diagnovus, founded in 2011 and located in Nashville, TN, specializes in molecular diagnostics aimed at rare cancers, including pediatric forms. The company is committed to developing innovative diagnostic tests that enhance the decision-making process for physicians, patients, and families dealing with challenging health conditions. By focusing on evidence-based products, Diagnovus aims to improve patient outcomes, support healthcare providers in delivering more effective care, and promote the efficient use of healthcare resources. Through its dedication to improving health and treatment quality, Diagnovus seeks to make a significant impact in the field of molecular diagnostics.
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile. Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.
OnFocus Healthcare, originally established in 1985 as a healthcare strategic planning consulting firm, transitioned in 2008 to focus on business execution software solutions. It specializes in providing enterprise performance management (EPM) software and support services tailored for the healthcare sector. Its flagship product, onFocus epm™, is designed to enhance patient care by enabling hospitals to improve their operational performance and execution capabilities. The software facilitates effective communication, management, and tracking of plans, metrics, and resources, promoting accountability within healthcare organizations. OnFocus Healthcare aims to boost the performance of its clients by at least 20%, supporting executives, managers, and employees in their efforts to deliver better, faster, and more cost-effective care.